What is the price of Pangaea Oncology, S.A. (PANG)

The price of Pangaea Oncology, S.A. (PANG) is $1.84

What is the market cap of Pangaea Oncology, S.A. (PANG)

The market cap of Pangaea Oncology, S.A. (PANG) is $66.03M

Pangaea Oncology, S.A. (PANG) Stock Splits

Pangaea Oncology, S.A. delivers essential medical services to cancer patients across Spain and other European Union countries. Its extensive offerings encompass advanced molecular diagnostics, which include mutation analysis in tumor tissue and blood, gene amplification and translocation testing, immunohistochemistry, and gene expression profiling. The company is also active in clinical trials and provides in vitro drug profiling, employing techniques like MTT proliferation assays, western blotting, colony formation, migration and invasion assays, and gene silencing. Furthermore, Pangaea operates a specialized Dx platform for validating companion diagnostic platforms, benchmarking them against commercial alternatives, and offering bespoke research and development services to other diagnostic firms. A key focus also involves biomarker discovery, aiming to pinpoint novel targets for targeted therapies in their pre-clinical stages. Established in 2006, Pangaea Oncology, S.A. is headquartered in Barcelona, Spain.

Year	Split	Multiple	Cumulative Multiple
Not enough data for the provided dates.

Year

Split

Multiple

Cumulative Multiple

Not enough data for the provided dates.

Company	Number of stock splits	Cumulative Multiple	Country
Thermo Fisher Scientific Inc. TMO.US	8	x34	US
Danaher Corporation DHR.US	7	x47	US
WuXi AppTec Co., Ltd. 603259.SS	0	-	CN
Natera, Inc. NTRA.US	0	-	US
Agilent Technologies, Inc. A.US	1	x1	US

Company

Number of stock splits

Cumulative Multiple

Country